CD21 blocking peptide product blog
Tags: CD21; Blocking Peptide; CD21 blocking peptide;
The CD21 cr2 (Catalog #MBS542680) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s CD21 can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), IMM, Western Blot (WB).Immunoprecipitation: 1:150
Western Blot: 1:500. Researchers should empirically determine the suitability of the CD21 cr2 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The CD21 cr2 product has the following accession number(s) (GI #767908444) (NCBI Accession #XP_011507508.1) (Uniprot Accession #P20023). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Antigenic Blocking Peptide Complement Receptor Type 2 isoform X1 Antibody N-epitope
Receptor for complement C3Dd, for the Epstein-Barr virus on human B-cells and T-cells and for HNRPU. Participates in B lymphocytes activation.
Immunogen: Synthetic Peptide
Expression: Mature B-lymphocytes, T-lymphocytes, pharyngeal epithelial cells, astrocytes and follicular dendritic cells of the spleen. Determinant: N-epitope
Molecular Function: Complement binding; DNA binding; Protein homodimerization activity
Structure: Interacts (via Sushi domain 1 and 2) with C3dg.
Subcellular Location: Membrane; Single-pass type I membrane protein. Blood, Brain, Kidney, Liver, Lymph, Lymph Node, Spleen, Thymus, Tonsil, Vascular tissues are correlated with this protein. Disease Models, Animal, Immunologic Deficiency Syndromes, Inflammation, Liver Diseases, Lung Diseases, Lupus Erythematosus, Systemic, Necrosis, Neoplasms, Experimental, Sarcoma, Skin Diseases are some of the diseases may be linked to CD21 Antibody Antigenic Blocking Peptide. The following patways have been known to be associated with this gene.